Andrea Mccullough, MD Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 700 River Dr, Fort Bragg, CA 95437 Phone: 707-961-4655 |
Tamaki A. Myers, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 River Dr, Fort Bragg, CA 95437 Phone: 707-961-1234 |
Patrick Lenaghan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 707 River Dr, Fort Bragg, CA 95437 Phone: 202-247-7081 |
Dr. Richard Robert Reid, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 River Dr, Fort Bragg, CA 95437 Phone: 707-961-1234 |
News Archive
When this week's print issue of the journal Science comes out, a collective cheer will go up from New Mexico, Montana and even the Netherlands, thanks to the type of collaborative effort that is more and more the norm in these connected times. Yes, the research was brilliant, and if we're lucky, it will produce innovations in biology, medicine, biotechnology and agriculture. It could save lives, and it happened because this scientist talked with that one, that one knew another one, and brilliant minds overcame geographic distance to advance human understanding.
Researchers in China have conducted a phase 1/2 trial demonstrating the safety, tolerability, and immunogenicity of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
Xinyuan Chen, an assistant professor of biomedical and pharmaceutical sciences, joined URI's College of Pharmacy after seven years at Massachusetts General Hospital in Boston, bringing with him a $1.08 million career development grant from the National Institute of Drug Abuse and a $432,000 grant from the National Institute of Allergy and Infectious Disease.
Wyeth Pharmaceuticals, a division of Wyeth ( NYSE:WYE) , announced today that it has received approval from the U.S. Food and Drug Administration for XYNTHA(TM) (Antihemophilic Factor [Recombinant], Plasma/Albumin-Free), a recombinant factor VIII product, for patients with hemophilia A for both the control and prevention of bleeding episodes and surgical prophylaxis.
What do brilliantly colored glass, advanced batteries, and innovative technology for the regulation of brain functions have in common? They are nano-scale structures far smaller than the wavelengths of energy coursing through them in different regions of the electromagnetic spectrum, said NJIT Professor Haim Grebel.
› Verified 2 days ago